Median arcuate ligament syndrome (MALS) — also called celiac artery compression syndrome or Dunbar syndrome — is a condition in which the median arcuate ligament, a fibrous arch of the diaphragm that normally passes above the celiac axis, compresses the celiac artery at its aortic origin. This compression restricts blood flow to the celiac territory — the stomach, liver, pancreas, and spleen — and typically produces chronic postprandial upper abdominal pain that worsens after eating when the visceral organs' metabolic demand exceeds the restricted supply. MALS is one of the most underdiagnosed and diagnostically delayed conditions in abdominal medicine, with a typical diagnostic journey spanning years and multiple negative GI evaluations.
MALS is a vascular compression syndrome that must be distinguished from other causes of chronic upper abdominal pain — including gallbladder disease, pancreatic pathology, and functional GI disorders — and from other abdominal vascular compression syndromes including nutcracker syndrome (left renal vein compression) with which it can coexist. The celiac axis compression in MALS causes upstream blood flow redistribution that can secondarily dilate the superior mesenteric artery collaterals and produce a splenic artery aneurysm or other visceral artery dilation as a recognized downstream consequence. MR angiography with dynamic respiratory-phase imaging — capturing the celiac artery in both full inspiration and full expiration — is the definitive noninvasive study for characterizing this dynamic compression.
Causes
Anatomic compression of the celiac axis.
The median arcuate ligament is a fibrous arch formed by the junction of the left and right diaphragmatic crura as they join anteriorly over the aortic hiatus — the opening through which the aorta descends from the chest into the abdomen. In the majority of people, this arch passes well above the celiac artery origin. In a subset of individuals — estimated at 10–24% of the population on imaging — the ligament descends low enough to contact the superior aspect of the celiac artery, producing a characteristic "hooked" or "fish-hook" impression on its superior wall. This compression is dynamic: it worsens during exhalation (when the diaphragm rises and the ligament descends, increasing the compressive force) and partially or fully relieves during deep inspiration (when the diaphragm descends and moves the ligament away from the artery). The true MALS syndrome occurs only when this anatomic compression produces hemodynamically significant flow restriction and compatible symptoms — the majority of people with celiac compression on imaging have no symptoms whatsoever (celiac compression phenomenon vs. syndrome).
Other contributing factors.
MALS is most commonly diagnosed in women aged 30–50, though it occurs at any age. Thin body habitus — with reduced retroperitoneal and perivascular fat — reduces the cushioning between the ligament and the artery, increasing the likelihood of symptomatic compression. The celiac plexus — a dense network of sympathetic nerve fibers that surrounds the celiac axis — is directly involved in the compressive process, and entrapment or irritation of these nerves may account for the visceral hypersensitivity and food aversion that are hallmarks of the neurogenic component of MALS. The relative contributions of vascular ischemia (reduced celiac blood flow) and neurogenic mechanisms (celiac plexus irritation) to symptom production are debated — and this distinction has clinical implications for treatment selection and outcomes. Evidence suggests that some patients' symptoms are predominantly neurogenic and respond better to celiac plexus intervention than to purely vascular decompression.
Symptoms
The hallmark symptom of MALS is chronic postprandial epigastric or periumbilical pain — pain that develops 15–60 minutes after eating, when the visceral organs increase their metabolic demand and require augmented blood flow that the compressed celiac axis cannot deliver. The pain is typically described as cramping, burning, or aching, and is located in the epigastrium or upper abdomen. It is characteristically relieved by leaning forward (which opens the aortomesenteric angle and reduces ligament tension) — a posture that patients often adopt instinctively. Nausea, vomiting, and bloating accompany the pain in most patients. The most diagnostically significant behavioral consequence is sitophobia — food aversion from anticipatory fear of triggering pain — which leads to voluntary food restriction, significant weight loss (typically 10–15 kg over months), and progressive nutritional compromise. An abdominal bruit audible on auscultation over the upper abdomen — loudest during exhalation — is the pathognomonic physical sign and should be specifically sought in all patients with unexplained postprandial pain.
The chronic nature of MALS, combined with the absence of specific biomarkers and the overlap with functional GI disorders, often leads to extensive negative workups for conditions including peptic ulcer disease, irritable bowel syndrome, gastroparesis, and chronic mesenteric ischemia before the diagnosis is established. The diagnostic delay — averaging 5–6 years from symptom onset — has significant consequences including malnutrition, anxiety, and depression. This diagnostic journey is itself a reason to consider MALS proactively in young women with chronic postprandial pain and weight loss who have negative conventional GI evaluations.
Diagnosis
A meticulous history is the most important diagnostic step — the combination of postprandial epigastric pain, weight loss from food aversion, a forward-leaning pain-relief posture, and an expiratory upper abdominal bruit in a young or middle-aged woman should immediately raise clinical suspicion. Duplex ultrasound of the celiac artery in both inspiration and expiration — evaluating peak systolic velocity and the velocity change between phases — is the initial noninvasive screening study: a celiac artery peak systolic velocity exceeding 200 cm/s during expiration with significant reduction during inspiration is a positive screen. However, ultrasound is operator-dependent and limited by bowel gas in many patients.
An MRI of the abdomen with dynamic MR angiography (capturing the celiac axis in full inspiration and full expiration using breath-hold sequences or navigator-gated acquisitions) is the most comprehensive noninvasive diagnostic study. MRA demonstrates the characteristic "fish-hook" or "J-shaped" deformity of the celiac artery — a superior impression and smooth extrinsic narrowing of the proximal celiac axis — that is pathognomonic for MAL compression. Percentage stenosis is measured on expiratory images and compared to inspiratory images to document the dynamic nature of the compression. MRI also characterizes the post-stenotic celiac artery dilation that often develops distal to the compression, evaluates collateral blood flow through the superior mesenteric artery via the pancreaticoduodenal arcade, and identifies associated visceral artery aneurysms (particularly splenic artery aneurysm) that develop from the altered hemodynamics. Simultaneous evaluation of the pancreas, gallbladder, and diaphragm excludes other pathology contributing to the symptom complex. Catheter angiography with pressure gradient measurement remains the gold standard for hemodynamic confirmation before surgery.
Classification
MALS is classified by the relationship between anatomic compression and clinical symptoms.
- Celiac compression phenomenon (asymptomatic): Imaging demonstrates MAL compression of the celiac artery without associated symptoms. Present in approximately 10–24% of the general population on cross-sectional imaging. Does not require treatment; surveillance not generally indicated.
- Symptomatic MALS: Anatomic compression with hemodynamically significant narrowing and compatible postprandial symptoms after exclusion of other diagnoses. Candidate for multidisciplinary evaluation and consideration of surgical release.
- By compression severity: Mild (<50% stenosis on expiration), moderate (50–70%), severe (>70%). Severe compression is more likely to produce hemodynamic flow limitation and mesenteric ischemic symptoms; mild compression may produce predominantly neurogenic symptoms from celiac plexus entrapment.
Treatments
Treatment is reserved for symptomatic MALS after other causes have been thoroughly excluded and a multidisciplinary team agrees the diagnosis is established. Careful patient selection is the most important predictor of surgical success.
Conservative care and multidisciplinary evaluation: Before any invasive intervention, all alternative diagnoses must be systematically excluded — functional dyspepsia, gastroparesis, IBS, chronic pancreatitis, and superior mesenteric artery syndrome (another mesenteric compression syndrome producing postprandial pain) must be evaluated. Nutritional rehabilitation with oral supplementation or enteral feeding may be needed before surgery in severely malnourished patients. Psychological evaluation and treatment of comorbid anxiety and depression — which develop in response to the chronic pain and food aversion — improves post-surgical outcomes. Pain management with neuromodulating agents (gabapentin, tricyclics) addresses the neurogenic pain component.
Celiac plexus nerve block.
CT or EUS-guided celiac plexus block with local anesthetic (with or without corticosteroid) can be both diagnostic and therapeutic — a positive response with meaningful pain reduction supports the diagnosis of MALS and predicts a favorable response to surgical celiac plexus neurolysis at the time of MAL release. In patients with predominantly neurogenic symptoms and mild vascular compression, celiac plexus block may provide months of relief.
Surgical median arcuate ligament release.
Division of the median arcuate ligament and the surrounding fibrous tissue to decompress the celiac axis is the definitive treatment for MALS. Laparoscopic or robotic-assisted release has become the preferred surgical approach at experienced centers, allowing precise division of the compressive tissue with shorter recovery than open surgery. The procedure includes division of the MAL fibers, release of the celiac plexus ganglia, and sometimes resection of surrounding fibrous and neural tissue (celiac ganglionectomy) to maximize both vascular and neurogenic decompression. Most surgeons perform intraoperative Doppler assessment of celiac flow to confirm hemodynamic improvement before closing. Symptom improvement is reported in approximately 70–85% of carefully selected patients at 1 year; longer-term outcomes are variable and depend heavily on the relative contribution of neurogenic vs. vascular mechanisms. Persistent or recurrent symptoms after MAL release may require celiac artery stenting for residual stenosis or repeat celiac plexus block for persistent neurogenic pain.
Celiac artery stenting.
Endovascular stenting of the celiac artery without prior surgical MAL release is generally not recommended as a primary treatment — the ligament compressive force remains and stent fracture or kinking from dynamic compression is a recognized complication. Stenting is appropriately used for residual celiac stenosis identified after surgical release has eliminated the compressive force, or in patients who are not surgical candidates.
Get an MRI to Confirm Your Diagnosis
Before surgical planning or starting treatment, a clear MRI diagnosis ensures the right path forward. First Look MRI offers self-pay Abdomen MRI scans — no doctor's order or insurance required — at our locations in Georgia, Texas, and Colorado.